What is the current stock price of Novozymes A/S (NVZMY)?

As of the latest market data, Novozymes A/S (NVZMY) is trading at $60.04. The stock has seen a gain of 0.10% today.

Does Novozymes A/S (NVZMY) pay a dividend?

Based on current data, Novozymes A/S does not have a confirmed active dividend policy.

What is the market cap of Novozymes A/S?

The current market capitalization of Novozymes A/S (NVZMY) is approximately unavailable.

NVZMY

Novozymes A/S·Basic Materials

60.04

0.100%(+0.06)

Market Closed

Last Updated: — ET

52W L: $49.9052W H: $75.99

NVZMY NEWS

zacks.com

Mar 31

FUL or NVZMY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY).

defenseworld.net

Mar 8

Analyzing Novozymes A/S (OTCMKTS:NVZMY) & Orion (NYSE:OEC)

Orion (NYSE: OEC - Get Free Report) and Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk. Institutional and Insider Ownership 94.3% of Orion shares

seekingalpha.com

Feb 25

Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript

zacks.com

Feb 3

NVZMY vs. HWKN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Novozymes A/S (NVZMY) or Hawkins (HWKN). But which of these two stocks offers value investors a better bang for their buck right now?

defenseworld.net

Jan 13

Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 84,786 shares, an increase of 19,526.4% from the December 15th total of 432 shares. Based on an average daily volume of 118,101 shares, the

Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Sector

Basic Materials

Industry

Chemicals - Specialty

Employees

10,582

IPO Date

2010-01-20

Beta

0.65

Websitewww.novozymes.com↗